Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis

More than 75% of cost utility analyses were published one year or more after publication of the trial's clinical results Comment We found a substantial delay in the publication of cost utility analyses, suggesting that reliable economic data are usually not available, at least in peer reviewed...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 328; no. 7455; pp. 1536 - 1537
Main Authors Greenberg, Dan, Rosen, Allison B, Olchanski, Natalia V, Stone, Patricia W, Nadai, John, Neumann, Peter J
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 26.06.2004
BMJ Publishing Group
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
EditionInternational edition
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:More than 75% of cost utility analyses were published one year or more after publication of the trial's clinical results Comment We found a substantial delay in the publication of cost utility analyses, suggesting that reliable economic data are usually not available, at least in peer reviewed journals, for decision makers when decisions on adoption and reimbursement are typically made. [...]compared with trial results, dissemination of cost utility analyses takes place in journals with lower readership and influence.
Bibliography:href:bmj-328-1536.pdf
Correspondence to: D Greenberg, Harvard Clinical Research Institute, 930 Commonwealth Avenue, Boston, MA 02215, USA
local:bmj;328/7455/1536
ArticleID:bmj.38079.502326.AE
PMID:15100148
istex:C3B6CF3A8A1952C20C5D64162B89FCC7369B97B7
ark:/67375/NVC-BQ2Q07ZX-9
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was posted on bmj.com on 20 April 2004: http://bmj.com/cgi/doi/10.1136/bmj.38079.502326.AE
Contributors: DG had the original idea for the study, drafted the first version of the manuscript, did the statistical analysis, and is the guarantor. All authors extracted data, interpreted the findings, critically revised the report, and approved the final version.
Funding: Supported by grant number R01 HS10919 from the Agency for Health Care Research and Quality.
Correspondence to: D Greenberg, Harvard Clinical Research Institute, 930 Commonwealth Avenue, Boston, MA 02215, USA dan.greenberg@hcri.harvard.edu
We thank Richard H Chapman for his contribution to the design and analysis of the Harvard School of Public Health Cost-Effectiveness Analysis Registry.
Competing interests: None declared.
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.38079.502326.AE